All News

The study results support a hypothesis for a differentiated mechanism from risankizumab, the company says.

This month's Rx product news features empagliflozin, mitapivat, and RSVpreF.

Sacubitril/valsartan (Entresto)reduces the risk of hospitalization and death related to cardiovascular complications in patients with heart failure.

Byron Yoshino, PharmD, CEO of Pharmacare Hawaii, discusses the future of the home infusion space within the United States in the coming years.

Investigators found that 51% of participants achieved sustained unresponsiveness to peanut after 18 months of treatment.

Dr. Jacinda Abdul-Mutakabbir is dedicated to magnifying and rectifying health inequities in minoritized communities, which is why health equity is so important to her in healthcare.

Without sufficient vitamin D exposure, bones can become thin, brittle, or misshapen; however, excessive amounts of vitamin D are toxic.

This product helps control blood pressure.

Symtuza, a 4-drug combination of darunavir (DRV), a HIV-1 protease inhibitor; cobicistat (COBI), a CYP3A inhibitor; and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, is indicated as a complete regimen for the treatment of HIV-1 infection in patients who weigh at least 40 kg.

One example that has already been done in the past relates to understanding how to better measure insulin persistence.

US providers report substantial disruptions in vital supplies of saline injections, prefilled syringes.

This month's OTC Cases focuses on heartburn, pinworm infection, and food poisoning.

Byron Yoshino, PharmD, CEO of Pharmacare Hawaii, discusses the rapidly growing home infusion space within Pharmacare Hawaii’s network of pharmacies.

The FDA has approved abrocitinib tablets to treat adults with moderate-to-severe, refractory atopic dermatitis.

In patients already using analgesics for pain control, pharmacists need to address medication adherence for improved osteoarthritis symptom control.

Issues like medication access and transportation cost all impact a patient's ability to have access to medications and use them safely and effectively.

The vaccine is also credited with saving more than $30 billion in health care costs and more than $40 billion in lost productivity.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses whether patient out of pocket costs rose in 2021, and what the implications may be for the health care system and for patients in 2022.

Independent pharmacies' constant battle over the years to try and get relief for NCPA members on these retroactive DIR fees have been really the number one issue.

Comfort Ear soothes dry, irritated ears.

Prezista is an protease inhibitor indicated for the treatment of HIV-1 infection in patients aged 3 years and older.

It's really opening up the world for pharmacists to develop more meaningful measures and get at patient reported and clinical outcome measures.

Health systems should review HHS’ action plan and determine how to leverage cost savings to help eradicate HCV.

Here are 9 tips for employers to address employees’ feeling of detachment, exhaustion, and reduced accomplishment.

This month's product news features beet gummies, nerve relief, and acne blemish patches.

Approved by the FDA in 2021, finerenone is the only non-steroidal mineralocorticoid receptor antagonist that reduces the risk of renal disease progression and cardiovascular events in adults with type 2 diabetes mellitus-mediated chronic kidney disease.

It's extremely important for pharmacists to be involved in helping care for people who have HIV.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses the implications of the increase in spending on medicines in the United States in 2021.